Target intelligence / Profile preview

Inositol second messenger system

Molecular classification
Other (signaling system/pathway), Includes G protein-coupled receptors (upstream components), Includes ligand-gated ion channels (IP3 receptor downstream component)
01

Overview

The Inositol second messenger system refers to a signal transduction pathway wherein extracellular ligands (such as hormones and neurotransmitters) activate membrane receptors—most commonly G protein-coupled receptors—which in turn activate phospholipase C. This enzyme hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) to generate two intracellular messengers: inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 diffuses through the cytoplasm and binds to its receptor on the endoplasmic reticulum, triggering calcium ion release into the cytosol, which then activates various downstream processes including muscle contraction, secretion, metabolism, and changes in gene expression. DAG remains in the membrane and activates protein kinase C, further propagating the signal. The system plays a central role in cellular signaling and physiological regulation across many cell types, and is indirectly involved in a broad spectrum of diseases owing to its regulation of calcium and kinase signaling. The system itself is not a drug target, but its individual molecules (e.g., the IP3 receptor) are pharmacologically targetable.

Other names
Phosphoinositol signaling pathwayIP3 signaling pathwayinositol lipid signaling
02

Mechanism of action

For pathway components (e.g., IP3 receptor antagonists), mechanisms include inhibition of Ca2+ release from ER; PLC inhibitors prevent IP3/DAG formation

03

Biological functions

Signal transductionCalcium ion release/mobilizationCell proliferationMuscle contractionSecretionMetabolismSensory transductionLearning and memory (via IP3 receptor effects)
04

Disease associations

Neurodegenerative disease (dysregulation)Heart disease (disturbed Ca2+ signaling)Cancer (aberrant proliferation)Metabolic disorders
05

Safety considerations

Altered calcium signaling can cause arrhythmiaNeurotoxicityMuscle dysfunctionDisrupted cellular homeostasis
06

Biomarkers

IP3 (in some contexts)DAG (in some contexts)Ca2+ (in some contexts)Expression of IP3 receptors (in some contexts)

Beyond the preview

Go deeper on Inositol second messenger system.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inositol second messenger system.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call